(주)헬스바이옴


ABOUT US

Due to revolutionary development of DNA sequencing analysis technology, association between microbiome of human body and disease is being
proved. In particular, intestinal microbiome (stool) of healthy people is being demonstrated to have efficacy in treatment and prevention of
diversified diseases, as a result of which microbiome of human body is expected to be capable of development into a next-generation food.

Through the differentiated separation technology for strain with excellent efficacy for disease treatment using hard-to-cultivate and absolutely
anaerobic intestinal microbe strains, our business has secured independent strains that are effective particularly for metabolic disease, brain
disease and cancer immunotherapy enhancement, and is studying and investigating activated massive cultivation technology of disease-treating
strains and microbiome-based disease-treating compositions through multi-omics analysis and animal experiments.

  • tel. +82-70-4348-4130

  • time. 09:00~18:00 Closed Sat, Sun, Holidays